Results 131 to 140 of about 1,590 (205)
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT A 41‐year‐old man developed three distinct primary malignancies—acute myeloid leukemia, male breast cancer, and metastatic colorectal cancer—within 7 years. This rare case highlights the evolving challenge of multiple primary cancers and demonstrates how coordinated multidisciplinary care can preserve curative intent despite successive life ...
Abolfazl Khalafi‐Nezhad +3 more
wiley +1 more source
Cancer Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background The recent fifth edition of World Health Organization and International Consensus Classification in 2022 recognized TP53‐mutated myelodysplastic neoplasms (MDS) as a distinct entity requiring multi‐hit classification. Literatures indicate that TP53 variant alle frequency (VAF) correlates with clinical outcomes.
Yanming Cheng +7 more
wiley +1 more source
Association of Circulating Tumor DNA With Brain Metastases: A Systematic Review and Meta‐Analysis
CNS Neuroscience &Therapeutics, Volume 32, Issue 6, June 2026.This meta‐analysis of 1763 patients confirms ctDNA as a key biomarker for brain metastases. While plasma ctDNA effectively indicates metastatic risk and tumor burden, CSF ctDNA offers superior prognostic value for survival. Integrating both biomarkers into clinical workflows optimizes risk assessment and guides precision treatment for intracranial ...
Shaobo Yang +5 more
wiley +1 more source
Food Science &Nutrition, Volume 14, Issue 6, June 2026.Flavor profiles of untreated pea protein isolate (light green, solid line) compared to High Pressure Homogenization (HPH) treated (dark blue, dash‐dot line) and High Hydrostatic Pressure (HHP) treated pea protein isolates (dark green, dashed line). Samples were described as mainly pea‐like/bean‐like, flour‐like/cereal‐like, bitter, fatty, and sour ...
Lea Friedrich +4 more
wiley +1 more source
HemaSphere, Volume 10, Issue 6, June 2026.Abstract In HIV‐ and tuberculosis (TB)‐endemic regions, lymphoma diagnosis is often delayed because symptoms can overlap with TB, and access to biopsy and specialized pathology is limited. To address this, we developed and internally evaluated the Access to Diagnosis using Liquid Biopsy (ADLiB) platform—a plasma cell‐free DNA (cfDNA)‐based approach ...
Katherine Antel +21 more
wiley +1 more source